OPKO Health Operating Expenses 2010-2024 | OPK

OPKO Health operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
OPKO Health Annual Operating Expenses
(Millions of US $)
2023 $1,021
2022 $1,230
2021 $1,756
2020 $1,378
2019 $1,176
2018 $1,161
2017 $1,242
2016 $1,214
2015 $590
2014 $237
2013 $176
2012 $84
2011 $51
2010 $40
2009 $27
OPKO Health Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $244
2024-03-31 $245
2023-12-31 $251
2023-09-30 $243
2023-06-30 $258
2023-03-31 $268
2022-12-31 $241
2022-09-30 $268
2022-06-30 $321
2022-03-31 $402
2021-12-31 $464
2021-09-30 $348
2021-06-30 $437
2021-03-31 $507
2020-12-31 $445
2020-09-30 $406
2020-06-30 $274
2020-03-31 $252
2019-12-31 $337
2019-09-30 $268
2019-06-30 $274
2019-03-31 $298
2018-12-31 $312
2018-09-30 $283
2018-06-30 $269
2018-03-31 $298
2017-12-31 $319
2017-09-30 $294
2017-06-30 $318
2017-03-31 $312
2016-12-31 $245
2016-09-30 $322
2016-06-30 $329
2016-03-31 $319
2015-12-31 $284
2015-09-30 $151
2015-06-30 $68
2015-03-31 $87
2014-12-31 $58
2014-09-30 $68
2014-06-30 $58
2014-03-31 $53
2013-12-31 $57
2013-09-30 $40
2013-06-30 $42
2013-03-31 $38
2012-12-31 $26
2012-09-30 $21
2012-06-30 $20
2012-03-31 $18
2011-12-31 $14
2011-09-30 $13
2011-06-30 $13
2011-03-31 $11
2010-12-31 $5
2010-09-30 $10
2010-06-30 $13
2010-03-31 $12
2009-12-31 $1
2009-09-30 $7
2009-06-30 $8
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.130B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $233.063B 27.94
Intuitive Surgical (ISRG) United States $171.313B 97.00
Alcon (ALC) Switzerland $47.672B 33.56
IQVIA Holdings (IQV) United States $44.239B 25.07
IDEXX Laboratories (IDXX) United States $42.083B 50.62
Edwards Lifesciences (EW) United States $40.680B 26.07
DexCom (DXCM) United States $27.834B 39.69
STERIS (STE) Ireland $23.508B 27.43
SONOVA HOLDING (SONVY) Switzerland $20.781B 0.00
Waters (WAT) United States $19.789B 29.50
Hologic (HOLX) United States $18.981B 20.64
Sysmex ADR (SSMXY) Japan $12.317B 38.62
Fresenius Medical Care AG KGaA (FMS) Germany $12.224B 13.70
Teleflex (TFX) United States $11.380B 17.69
Globus Medical (GMED) United States $9.423B 26.36
Penumbra (PEN) United States $7.597B 78.86
Glaukos (GKOS) United States $6.721B 0.00
Masimo (MASI) United States $6.081B 32.57
TransMedics (TMDX) United States $5.203B 222.80
PROCEPT BioRobotics (PRCT) United States $4.309B 0.00
Integer Holdings (ITGR) United States $4.304B 25.17
Tandem Diabetes Care (TNDM) United States $2.791B 0.00
LivaNova (LIVN) United Kingdom $2.773B 16.26
Veracyte (VCYT) United States $2.593B 160.76
Inari Medical (NARI) United States $2.586B 0.00
Elekta AB (EKTAY) Sweden $2.562B 20.88
Nihon Kohden (NHNKY) Japan $2.508B 15.61
RxSight (RXST) United States $2.003B 0.00
Integra LifeSciences Holdings (IART) United States $1.360B 6.19
Pulse Biosciences (PLSE) United States $1.163B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.112B 19.84
Artivion (AORT) United States $1.046B 96.04
Alphatec Holdings (ATEC) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.728B 0.00
Mesa Laboratories (MLAB) United States $0.682B 17.23
SiBone (SIBN) United States $0.654B 0.00
AxoGen (AXGN) United States $0.638B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.616B 0.00
IRadimed (IRMD) United States $0.614B 33.19
Paragon 28 (FNA) United States $0.581B 0.00
Pacific Biosciences Of California (PACB) United States $0.526B 0.00
Treace Medical Concepts (TMCI) United States $0.341B 0.00
Sight Sciences (SGHT) United States $0.330B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 9.98
ClearPoint Neuro (CLPT) United States $0.322B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Inogen (INGN) United States $0.253B 0.00
Delcath Systems (DCTH) United States $0.251B 0.00
Nevro (NVRO) United States $0.217B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.190B 0.00
CVRx (CVRX) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Semler Scientific (SMLR) United States $0.173B 12.15
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.135B 0.00
908 Devices (MASS) United States $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.122B 0.00
EDAP TMS S.A (EDAP) France $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.099B 14.81
Hyperfine (HYPR) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Neuronetics (STIM) United States $0.029B 0.00
Lifeward (LFWD) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00